Skip to main content

Table 4 Illustration of the reported therapeutic targets that are regulated by LHR activation

From: Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation

Type Target name LHR+ LH1 LH4 LH8 LH20
Research Endothelin-1 (ET-1) -1.1 10.2 4.3 1.8 2.1
Research Stromal cell-derived factor 1 (SCD-1) 1.2 1.6 10.3 6.3 4.2
Research Insulin-like growth factor II (IGF2) -8.7 8.6 11.6 3.9 9.2
Clinical trail Kinesin-like protein KIF11 (KIF11) -1.5 -1.1 -2.3 -1.3 -1.6
  1. Fold changes are shown; the category (successful, clinical trial or research) indicates the different phase of the therapeutic targets discovery.